Gastroesophageal reflux disease

Springer Science and Business Media LLC - Tập 1 Số 1 - Trang 40-48 - 1998
Stuart J. Spechler1
1Division of Gastroenterology, Dallas VA Medical Center, Dallas

Tóm tắt

Từ khóa


Tài liệu tham khảo

Richter JE: Extraesophageal presentations of gastroesophageal reflux disease. Semin Gastrointest Dis 1997, 8:75–89.

Orlando RC: Why is the high grade inhibition of gastric acid secretion afforded by proton pump inhibitors often required for healing of reflux esophagitis? An epithelial perspective. Am S Gastroenterol 1996, 91:1692–1696.

Kahrilas PT: Gastroesophageal reflux disease. JAMA 1996, 276:983–988.

Wesdorp ICE, Dekker W, Festen HPM: Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitis. Dig Dis Sci 1993, 12:2287–2293.

DeVault KR, Castell DO: Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Arch Intern Med 1995, 155:2165–2173.

Wolfe MM: H2-receptor antagonists as OTC medications: how beneficial have they been? Practical Gastroenterology 1996, 20:S10-S16.

Hetzel DJ, Dent J, Reed WD, Narielvala FM, et al.: Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988, 95:903–912.

Castell DO, Richter JE, Robinson K, et al.: Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group. Am I Gastroenterol 1996, 91:1749–1757.

Holloway RH, Dent J, Narielvala, Mackinnon AM: Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patents with severe reflux oesophagitis. Gut 1996, 38:649–654.

Dent J, Yeomans ND, Mackinnon M, et al.: Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. Gut 1994, 35:590–598.

Vigneri S, Termini R, Leandro G, et al.: A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995, 333:1106–1110.

Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ, et al.: Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 1994, 121:161–167.

Dunnington GL, DeMeester TR: The outcome effect of adherence to operative principles of Nissen fundoplication by multiple surgeons. Am J Surg 1993, 166:654–657.

Jamieson GG: Anti-reflux operations: how do they work? Br J Surg 1987, 74:155–156.

Peters JK, Heimbucher J, Kauer WK, Incarbone R, et al.: Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication. J Am Coll Surg 1995, 180:385–393.

Spechler SJ: Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med 1992, 326:786–92.

Hinder RA, Filipi CJ, Wetscher G, et al.: Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg 1994, 220:472–481.

Jamieson GG, Watson DI, Britten-Jones R, Mitchell PC, Anvari M: Laparoscopic Nissen fundoplication. Ann Surg 1994, 220:137–145.

Anvari M, Allen C, Borm A: Laparoscopic Nissen fundoplication is a satisfactory alternative to long-term omeprazole therapy. Br J Surg 1995, 82:938–942.

Collet D, Cadiere GB: Conversions and complications of laparoscopic treatment of gastroesophageal reflux disease. Formation for the Development of Laparoscopic Surgery for Gastroesophageal Reflux Disease Group. Am J Surg 1995, 169:622–626.

Gotley DC, Smithers BM, Rhodes M, et al.: Laparoscopic Nissen fundoplication - 200 consecutive cases. Gut 1996, 38:487–491.

Collard JM, de Gheldere CA, De Kock M, Kestens PJ: Laparoscopic antireflux surgery. What is real progress? Ann Surg 1994, 220:146–154.

Rattner DW, Brooks IC: Patient satisfaction following laparoscopic and open antireflux surgery. Arch Surg 1995, 130:289–294.

DeMeester TR, Bonavina L, Albertucci M: Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg 1986, 204:9–20.

Brand DL, Eastwood IR, Martin D, et al.: Esophageal symptoms, manometry, and histology before and after antireflux surgery. A long-term follow-up study. Gastroenterology 1979, 76:1393–1401.

Luostarinen M, Isolauri J, Laitinen J, et al.: Fate of Nissen fundoplication after 20 years. A clinical, endoscopical, and functional analysis. Gut 1993, 34:1015–1020.

Soper NJ, Brunt LM, Kerbl K: Laparoscopic general surgery. N Engl J Med 1994, 330:409–419.

Collen MJ, Johnson DA: Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett’s esophagus. Dig Dis Sci 1992, 37:570–576.

Coley CM, Barry MJ, Spechler SJ, et al.: Initial medical vs. surgical therapy for complicated or chronic gastroesophageal reflux disease (GERD): A cost-effectiveness analysis. Gastroenterology 1993, 104:A5.

Vand den Boom G, Go PM, Hameeteman W, et al.: Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the Netherlands. Scand J Gastroenterol 1996, 31:1–9

Harding SM, Richter JE, Guzzo MR, Schan CA, et al.: Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med 1996, 100:395–405.

Hanson DG, Kamel PL, Kahrilas PJ: Outcomes of antireflux therapy for the treatment of chronic laryngitis. Ann Otol Rhinol Laryngol 1995, 104:550–555.

Deveney CW, Benner K, Cohen J: Gastroesophageal reflux and laryngeal disease. Arch Surg 1993, 128:1021–1027.